This is the text extract for 2010-09 Schedule Dispatch, browse documents here.

---

76 18 August 2010 September 2010 Pharmaceutical Schedule Dispatch This document is provided to pharmacists as an early notification of the changes to be announced in the September 2010 Update to the Pharmaceutical Schedule. Please notify PHARMAC (0800 66 00 50) to change or remove your contact details.

New listings · Insulin glulisine (Apidra) inj 100 u per ml, 3 ml (p’code 2361620) · Mucilaginous laxatives (Konsyl-D) dry 500 g OP – Only on a prescription (p’code 2358727) · Vitamin B complex (B-PlexADE) tab, strong BPC (p’code 2360888) · Clopidogrel (Apo-Clopidogrel) tab 75 mg, 90 cap pack (p’code 2354896) · Sodium bicarbonate (Sodibic) cap 840 mg (p’code 2085992) · Furosemide (Frusemide-Claris) inj 10 mg per ml, 2 ml – Up to 5 inj available on a PSO (p’code 2325357) · Ceftriaxone sodium (Veracol) inj 500 mg – Subsidy by endorsement – Up to 5 inj available on a PSO (p’code 2348551) · Cephalexin (Cephalexin ABM) cap 500 mg (p’code 2361248) · Meloxicam (Arrow-Meloxicam) tab 7.5 mg – Special Authority – Retail pharmacy (p’code 2347253) · Tenoxicam (AFT) inj 20 mg (p’code 2307022) · Zoledronic acid (Aclasta) soln for infusion 5 mg in 100 ml – Special Authority – Retail pharmacy (p’code 2274876) · Lignocaine hydrochloride (Xylocaine) inj 2%, 5 ml (p’code 311235) and 20 ml (p’code 705721) – Up to 5 inj available on a PSO · Lignocaine hydrochloride (Xylocaine Viscous) viscous solution 2%, 200 ml (p’code 290513) · Cyclizine lactate (Nausicalm) inj 50 mg per ml, 1 ml (p’code 2349655) · Fluorouracil sodium (Baxter) inj 1 mg for ECP, 100 mg – PCT only – Specialist (p’code 2370123) · Mesna (Baxter) inj 1 mg for ECP, 100 mg – PCT only – Specialist (p’code 2370131) · Sodium cromoglycate (Rexacrom) eye drops 2%, 5 ml OP (p’code 2224291) Changes to restrictions · Acarbose (Glucobay) tab 50 mg and 100 mg – removal of Special Authority criteria · Pioglitazone (Pizaccord) tab 15 mg, 30 mg and 45 mg – amended Special Authority criteria · Multivitamins (Paediatric Seravit) powder – amended Special Authority criteria · Clopidogrel (Apo-Clopidogrel, Arrow-Clopidogrel, Plavix) tab 75 mg – removal of Special Authority criteria · Atorvastatin (Lipitor) tab 10 mg, 20 mg, 40 mg and 80 mg – removal of Special Authority criteria · Amiloride with hydrochlorothiazide (Moduretic) tab 5 mg with hydrochlorothiazide 50 mg – removal of Section 29 · Isotretinoin (Oratane) cap 10 mg and 20 mg – amended Special Authority criteria · Triclosan (healthE) soln 1% – addition of Original Pack · Malathion (A-Lices) liq 0.5% – addition of Original Pack · Azithromycin (Arrow-Azithromycin) tab 500 mg – increased quantity available on a PSO · Ethambutol hydrochloride (Myambutol) tab 100 mg and 400 mg – removal of Section 29 · Interferon alpha-2A (Roferon-A) inj prefilled syringe 3 m iu, 6 m iu and 9 m iu – removal of prescribing note A375323 Page 1 of 3

---

· · · · · · · · · · · · · · · · · · · ·

Anti-inflammatory Non Steroidal Drugs (NSAIDS) – removal of Special Authority criteria for new applicants Alendronate sodium (Fosamax) tab 70 mg - amended Special Authority criteria Alendronate sodium with cholecalciferol (Fosamax Plus) tab 70 mg with cholecalciferol 5,600 iu – amended Special Authority criteria Lignocaine (Pfizer) gel 2%, 10 ml urethral syringe – Up to 5 each available on a PSO Lignocaine hydrochloride (Xylocaine) inj 0.5%, 5 ml, inj 1%, 5 ml and inj 1%, 20 ml – removal of prescribing restriction Lignocaine with chlorohexidine (Pfizer) gel 2% with chlorohexidine 0.05%, 10 ml urethral syringes – Up to 5 each available on a PSO Ondansetron tab 4 mg and 8 mg (Zofran), and tab disp 4 mg and 8 mg (Zofran Zydis) – removal of Retail pharmacy – Specialist Tropisetron (Navoban) cap 5 mg – removal of Retail pharmacy – Specialist Alprazolam (Arrow-Alprazolam) tab 250 µg, 500 µg and 1 mg – removal of Month Restriction Buspirone hydrochloride (Pacific Buspirone) tab 5 mg and 10 mg – removal of Month Restriction Diazepam (Arrow-Diazepam) tab 2 mg and 5 mg – removal of Month Restriction Lorazepam (Ativan) tab 1 mg and 2.5 mg – removal of Month Restriction Oxazepam (Ox-Pam) tab 10 mg and 15 mg – removal of Month Restriction Lormetazepam (Noctamid) tab 1 mg – removal of Month Restriction Midazolam (Hypnovel) tab 7.5 mg – removal of Month Restriction Nitrazepam (Nitrados) tab 5 mg – removal of Month Restriction Temazepam (Normison) tab 10 mg – removal of Month Restriction Triazolam (Hypam) tab 125 µg and 250 µg – removal of Month Restriction Zopiclone (Apo-Zopiclone) tab 7.5 mg – removal of Month Restriction Capecitabine (Xeloda) tab 150 mg and 500 mg – amended Special Authority criteria

Decreased subsidy

Chemical Presentation Fully brands Moduretic Apo-Clopidogrel David Craig Myambutol Fluorouracil Ebewe Neurontin Neurontin healthE Xylocaine m-Eslon Ural ABM, Midwest, PSM subsidised Partially subsidised brands

Amiloride with hydrochlorothiazide Clopidogrel Coal tar Ethambutol hydrochloride Fluorouracil sodium Gabapentin (Neurontin)

Glycerol Lignocaine hydrochloride Morphine sulphate Sodium citro-tartrate

Tab 5 mg with hydrochlorothiazide 50 mg Tab 75 mg, 28 tab pack Soln BP Tab 100 mg and 400 mg Inj 50 mg per ml, 20 ml, 50 ml and 100 mg Tab 600 mg Cap 100 mg, 30 mg and 400 mg Liquid Inj 1%, 5 ml and 20 ml Cap long-acting 60 mg Grans eff 4 g sachets

Increased subsidy

Chemical Atorvastatin Captopril Dacarbazine Presentation Tab 10 mg, 20 mg, 40 mg and 80 mg Oral liq 5 mg per ml, 95 ml OP Inj 200 mg Fully brands Lipitor Capoten Hospira subsidised

A375323 Page 2 of 3

---

Fluorouracil sodium Flutamide Haloperidol Hydrocortisone Ibuprofen Lignocaine with prilocaine

Mesna

Methotrexate

Inj 200 mg for ECP Inj 50 mg per ml, 10 ml Tab 250 mg Tab 500 μg, 1.5 mg and 5 mg Oral liq 2 mg per ml Inj 5 mg per ml, 1 ml Inj 50 mg per ml, 2 ml Tab long-acting 800 mg Crm 2.5% with pirlocaine 2.5 %, 30 g OP Crm 2.5% with prilocaine 2.5% (5 g tubes) Tab 400 mg and 600 mg Inj 100 mg per ml, 4 ml and 10 ml Inj 25 mg per ml, 2 ml and 20 ml Inj 1 mg for ECP Cap long-acting 10 mg, 30 mg and 100 mg Inj 80 mg per ml, 1.5 ml and 5 ml Aerosol inhaler, 2 mg per dose CFC-free Tab 500,000 u Cap 500,000 u Cap potassium salt 250 mg Cap potassium salt 500 mg Inj 23.4%, 20 ml Powder for inhalation, 20 mg per dose Aerosol inhaler, 5 mg per dose CFC-free Oral liq 80 mg per 15 ml

Baxter Fluorouracil Ebewe Flutamin Serenace Serenace Serenace Solu-Cortef Brufen Retard EMLA EMLA Uromitexan Uromitexan Hospira Baxter m-Eslon Hospira Tilade Nilstat Nilstat Cilicaine VK Cilicaine VK Biomed Intal Spincaps Vicrom Nuelin

Morphine sulphate Morphine tartrate Nedocromil Nystatin Phenoxymethylpenicillin (Penicillin V) Sodium chloride Sodium cromoglycate

Theophylline

NB. For further details and magnitude of the above subsidy changes, please consult the online version of the Update to the Pharmaceutical Schedule at: www.pharmac.govt.nz/healthpros/Schedule.

A375323 Page 3 of 3